CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia

Cell Stem Cell

Volumn 17, Issue 4, 2015, Pages 412-421

  Iwasaki, Masayuki ^a   Liedtke, Michaela ^a   Gentles, Andrew J ^a   Cleary, Michael L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD93; CDKN2B; leukemia stem cells; MLL

Indexed keywords

ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CD93 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2B; LECTIN; MIXED LINEAGE LEUKEMIA PROTEIN; TRANSCRIPTION FACTOR HOXA9; UNCLASSIFIED DRUG; CDKN2B PROTEIN, HUMAN; COMPLEMENT 1Q RECEPTOR; COMPLEMENT RECEPTOR; MEMBRANE PROTEIN; TUMOR MARKER;

ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CELL MATURATION; CELL POPULATION; DISEASE CLEARANCE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE REARRANGEMENT; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKEMIA; LEUKEMIA CELL; LEUKEMIA STEM CELL; LEUKEMOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; UPREGULATION; ACUTE MYELOID LEUKEMIA; BIOSYNTHESIS; CANCER STEM CELL; CELL SELF-RENEWAL; GENETICS; LEUKEMIA, BIPHENOTYPIC, ACUTE; LYMPHOID PROGENITOR CELL; METABOLISM; PATHOLOGY;

BIOMARKERS, TUMOR; CELL SELF RENEWAL; CYCLIN-DEPENDENT KINASE INHIBITOR P15; GENE REARRANGEMENT; HUMANS; LEUKEMIA, BIPHENOTYPIC, ACUTE; LEUKEMIA, MYELOID, ACUTE; LYMPHOID PROGENITOR CELLS; MEMBRANE GLYCOPROTEINS; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NEOPLASTIC STEM CELLS; RECEPTORS, COMPLEMENT;

EID: 84952630671     PISSN: 19345909     EISSN: 18759777     Source Type: Journal    
DOI: 10.1016/j.stem.2015.08.008     Document Type: Article

References (48)

1. A. Aggerholm, M.S. Holm, P. Guldberg, L.H. Olesen, and P. Hokland Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients Eur. J. Haematol. 76 2006 23 32
2. P.M. Ayton, and M.L. Cleary Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9 Genes Dev. 17 2003 2298 2307
3. M. Bhatia, J.C. Wang, U. Kapp, D. Bonnet, and J.E. Dick Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice Proc. Natl. Acad. Sci. USA 94 1997 5320 5325
4. J. Bies, M. Sramko, J. Fares, M. Rosu-Myles, S. Zhang, R. Koller, and L. Wolff Myeloid-specific inactivation of p15Ink4b results in monocytosis and predisposition to myeloid leukemia Blood 116 2010 979 987
5. D. Bonnet, and J.E. Dick Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nat. Med. 3 1997 730 737
6. C.S. Chim, R. Liang, C.Y.Y. Tam, and Y.L. Kwong Methylation of p15 and p16 genes in acute promyelocytic leukemia: potential diagnostic and prognostic significance J. Clin. Oncol. 19 2001 2033 2040
7. G.H. Danet, J.L. Luongo, G. Butler, M.M. Lu, A.J. Tenner, M.C. Simon, and D.A. Bonnet C1qRp defines a new human stem cell population with hematopoietic and hepatic potential Proc. Natl. Acad. Sci. USA 99 2002 10441 10445
8. M.A. Dao, J. Hwa, and J.A. Nolta Molecular mechanism of transforming growth factor beta-mediated cell-cycle modulation in primary human CD34(+) progenitors Blood 99 2002 499 506
9. H.G. Drexler Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells Leukemia 12 1998 845 859
10. K. Eppert, K. Takenaka, E.R. Lechman, L. Waldron, B. Nilsson, P. van Galen, K.H. Metzeler, A. Poeppl, V. Ling, J. Beyene, and et al. Stem cell gene expression programs influence clinical outcome in human leukemia Nat. Med. 17 2011 1086 1093
11. M.I. Fonseca, P.M. Carpenter, M. Park, G. Palmarini, E.L. Nelson, and A.J. Tenner C1qR(P), a myeloid cell receptor in blood, is predominantly expressed on endothelial cells in human tissue J. Leukoc. Biol. 70 2001 793 800
12. A.J. Gentles, S.K. Plevritis, R. Majeti, and A.A. Alizadeh Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia JAMA 304 2010 2706 2715
13. J.G. Herman, J. Jen, A. Merlo, and S.B. Baylin Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B Cancer Res. 56 1996 722 727
14. N. Hosen, C.Y. Park, N. Tatsumi, Y. Oji, H. Sugiyama, M. Gramatzki, A.M. Krensky, and I.L. Weissman CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia Proc. Natl. Acad. Sci. USA 104 2007 11008 11013
15. F. Ishikawa, S. Yoshida, Y. Saito, A. Hijikata, H. Kitamura, S. Tanaka, R. Nakamura, T. Tanaka, H. Tomiyama, N. Saito, and et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region Nat. Biotechnol. 25 2007 1315 1321
16. M. Iwasaki, T. Kuwata, Y. Yamazaki, N.A. Jenkins, N.G. Copeland, M. Osato, Y. Ito, E. Kroon, G. Sauvageau, and T. Nakamura Identification of cooperative genes for NUP98-HOXA9 in myeloid leukemogenesis using a mouse model Blood 105 2005 784 793
17. S. Jaiswal, C.H. Jamieson, W.W. Pang, C.Y. Park, M.P. Chao, R. Majeti, D. Traver, N. van Rooijen, and I.L. Weissman CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis Cell 138 2009 271 285
18. M. Jan, M.P. Chao, A.C. Cha, A.A. Alizadeh, A.J. Gentles, I.L. Weissman, and R. Majeti Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker Proc. Natl. Acad. Sci. USA 108 2011 5009 5014
19. L. Jin, K.J. Hope, Q. Zhai, F. Smadja-Joffe, and J.E. Dick Targeting of CD44 eradicates human acute myeloid leukemic stem cells Nat. Med. 12 2006 1167 1174
20. L. Jin, E.M. Lee, H.S. Ramshaw, S.J. Busfield, A.G. Peoppl, L. Wilkinson, M.A. Guthridge, D. Thomas, E.F. Barry, A. Boyd, and et al. Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells Cell Stem Cell 5 2009 31 42
21. C.T. Jordan, D. Upchurch, S.J. Szilvassy, M.L. Guzman, D.S. Howard, A.L. Pettigrew, T. Meyerrose, R. Rossi, B. Grimes, D.A. Rizzieri, and et al. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells Leukemia 14 2000 1777 1784
22. C.T. Jordan, M.L. Guzman, and M. Noble Cancer stem cells N. Engl. J. Med. 355 2006 1253 1261
23. Y. Kikushige, T. Shima, S. Takayanagi, S. Urata, T. Miyamoto, H. Iwasaki, K. Takenaka, T. Teshima, T. Tanaka, Y. Inagaki, and K. Akashi TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells Cell Stem Cell 7 2010 708 717
24. M.Y. Konopleva, and C.T. Jordan Leukemia stem cells and microenvironment: biology and therapeutic targeting J. Clin. Oncol. 29 2011 591 599
25. U. Krug, A. Ganser, and H.P. Koeffler Tumor suppressor genes in normal and malignant hematopoiesis Oncogene 21 2002 3475 3495
26. T. Lapidot, C. Sirard, J. Vormoor, B. Murdoch, T. Hoang, J. Caceres-Cortes, M. Minden, B. Paterson, M.A. Caligiuri, and J.E. Dick A cell initiating human acute myeloid leukaemia after transplantation into SCID mice Nature 367 1994 645 648
27. C. Lavau, S.J. Szilvassy, R. Slany, and M.L. Cleary Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL EMBO J. 16 1997 4226 4237
28. C. Li, and W.H. Wong Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection Proc. Natl. Acad. Sci. USA 98 2001 31 36
29. R. Majeti, M.P. Chao, A.A. Alizadeh, W.W. Pang, S. Jaiswal, K.D. Gibbs Jr., N. van Rooijen, and I.L. Weissman CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells Cell 138 2009 286 299
30. E.P. McGreal, N. Ikewaki, H. Akatsu, B.P. Morgan, and P. Gasque Human C1qRp is identical with CD93 and the mNI-11 antigen but does not bind C1q J. Immunol. 168 2002 5222 5232
31. R.R. Nepomuceno, A.H. HenschenEdman, W.H. Burgess, and A.J. Tenner cDNA cloning and primary structure analysis of C1qR(p), the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro Immunity 6 1997 119 129
32. R.R. Nepomuceno, and A.J. Tenner C1qRP, the C1q receptor that enhances phagocytosis, is detected specifically in human cells of myeloid lineage, endothelial cells, and platelets J. Immunol. 160 1998 1929 1935
33. P.J. Norsworthy, L. Fossati-Jimack, J. Cortes-Hernandez, P.R. Taylor, A.E. Bygrave, R.D. Thompson, S. Nourshargh, M.J. Walport, and M. Botto Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis J. Immunol. 172 2004 3406 3414
34. E. Passegué, A.J. Wagers, S. Giuriato, W.C. Anderson, and I.L. Weissman Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates J. Exp. Med. 202 2005 1599 1611
35. O. Petrenko, A. Beavis, M. Klaine, R. Kittappa, I. Godin, and I.R. Lemischka The molecular characterization of the fetal stem cell marker AA4 Immunity 10 1999 691 700
36. T. Placke, K. Faber, A. Nonami, S.L. Putwain, H.R. Salih, F.H. Heidel, A. Krämer, D.E. Root, D.A. Barbie, A.V. Krivtsov, and et al. Requirement for CDK6 in MLL-rearranged acute myeloid leukemia Blood 124 2014 13 23
37. Y. Saito, H. Kitamura, A. Hijikata, M. Tomizawa-Murasawa, S. Tanaka, S. Takagi, N. Uchida, N. Suzuki, A. Sone, Y. Najima, and et al. Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells Sci. Transl. Med. 2 2010 17ra9
38. T. Shimamoto, J.H. Ohyashiki, and K. Ohyashiki Methylation of p15(INK4b) and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia Leuk. Res. 29 2005 653 659
39. T.C.P. Somervaille, and M.L. Cleary Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia Cancer Cell 10 2006 257 268
40. T.C.P. Somervaille, C.J. Matheny, G.J. Spencer, M. Iwasaki, J.L. Rinn, D.M. Witten, H.Y. Chang, S.A. Shurtleff, J.R. Downing, and M.L. Cleary Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells Cell Stem Cell 4 2009 129 140
41. L. Teofili, R. Morosetti, M. Martini, R. Urbano, R. Putzulu, S. Rutella, L. Pierelli, G. Leone, and L.M. Larocca Expression of cyclin-dependent kinase inhibitor p15(INK4B) during normal and leukemic myeloid differentiation Exp. Hematol. 28 2000 519 526
42. L. Teofili, M. Martini, M. Luongo, D. Diverio, G. Capelli, M. Breccia, F. Lo Coco, G. Leone, and L.M. Larocca Hypermethylation of GpG islands in the promoter region of p15(INK4b) in acute promyelocytic leukemia represses p15(INK4b) expression and correlates with poor prognosis Leukemia 17 2003 919 924
43. A. van Rhenen, G.A.M.S. van Dongen, A. Kelder, E.J. Rombouts, N. Feller, B. Moshaver, M. Stigter-van Walsum, S. Zweegman, G.J. Ossenkoppele, and G. Jan Schuurhuis The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells Blood 110 2007 2659 2666
44. A. Ventura, A. Meissner, C.P. Dillon, M. McManus, P.A. Sharp, L. Van Parijs, R. Jaenisch, and T. Jacks Cre-lox-regulated conditional RNA interference from transgenes Proc. Natl. Acad. Sci. USA 101 2004 10380 10385
45. L. Wolff, M.T. Garin, R. Koller, J. Bies, W. Liao, M. Malumbres, L. Tessarollo, D. Powell, and C. Perella Hypermethylation of the Ink4b locus in murine myeloid leukemia and increased susceptibility to leukemia in p15(Ink4b)-deficient mice Oncogene 22 2003 9265 9274
46. I.H.N. Wong, M.H.L. Ng, D.P. Huang, and J.C.K. Lee Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implications Blood 95 2000 1942 1949
47. P. Wong, M. Iwasaki, T.C.P. Somervaille, C.W.E. So, and M.L. Cleary Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential Genes Dev. 21 2007 2762 2774
48. S. Zhang, X. Qian, C. Redman, V. Bliskovski, E.S. Ramsay, D.R. Lowy, and B.A. Mock p16 INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB Oncogene 22 2003 2285 2295